Wolman Disease Clinical Trial
Official title:
In Utero Enzyme Replacement Therapy (ERT) for Prenatally Diagnosed Lysosomal Storage Disorders (LSDs).
The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.
Because fetuses with these LSDs are at increased risk of serious perinatal morbidity and mortality, particularly in the setting of Non-Immune Hydrops Fetalis (NIHF), the administration of the approved enzyme therapy in utero has the potential to significantly improve outcomes for affected fetuses. The perinatal death rate associated with NIHF ranges from 30 to 75%, so development of an in utero approach to treatment could be of significant benefit. The in utero period has been shown to be a time of relative fetal tolerance to immune stimuli, and this tolerance may lead to improved response to ERT in situations where postnatal initiation instead leads to antibody development and impaired response to treatment. It is also probable that in some cases, initiation of ERT in utero leads to improved neurodevelopmental outcomes if the replaced enzyme impacts the neurologic system during critical periods of development. This is a phase 1 clinical trial to determine the safety and feasibility of fetal enzyme replacement therapy in fetuses with LSD ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00383448 -
HSCT for High Risk Inherited Inborn Errors
|
Phase 2 | |
| Completed |
NCT04652713 -
Breakfast for Young Women
|
N/A | |
| Terminated |
NCT01473875 -
Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102
|
Phase 2/Phase 3 | |
| Completed |
NCT01884220 -
Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
|
N/A | |
| Completed |
NCT01358370 -
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
|
N/A | |
| Completed |
NCT01371825 -
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05619900 -
Registry of Patients Diagnosed With Lysosomal Storage Diseases
|
||
| Not yet recruiting |
NCT04792671 -
Prevalence and Risk Factors of Women Mental Health Disorders
|
||
| Completed |
NCT00176904 -
Stem Cell Transplant for Inborn Errors of Metabolism
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01633489 -
Lysosomal Acid Lipase (LAL) Deficiency Registry
|
||
| Active, not recruiting |
NCT00005900 -
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT01586455 -
Human Placental-Derived Stem Cell Transplantation
|
Phase 1 | |
| Recruiting |
NCT06287658 -
The Effect of Kegel Exercise and Ba Duan Jin Applications on Premenopausal Women With Urinary Incontinence
|
N/A |